Robert A. Vescio, MD

Robert A. Vescio is a medical director at multiple myeloma and amyloidosis program in the Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai. He earned his medical degree from University of California, San Diego School of Medicine followed by residency and post doctorate from the same university. Dr. Vescio then completed fellowship from University of California, Los Angeles (UCLA) Medical Center.

Dr. Vescio is a specialist in internal medicine, hematology and oncology. His clinical areas include amyloidosis and multiple myeloma. His research interests include monoclonal gammopathy of undetermined significance, a related condition which in some cases develop into multiple myeloma. His laboratory work has led to an improved understanding of multiple myeloma pathogenesis, including a potential link with human herpes virus-8 infection. Dr. Vescio has been cited as one of the top specialists in multiple myeloma and amyloidosis in “America’s Top Doctors for Cancer.”

Representative Publications:

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-Agent Lorvotuzumab Mertansine (Imgn901) in Patients With Relapsed and/or Refractory Cd-56-Positive Multiple Myeloma

A Cd10-Positive Subset of Malignant Cells is Identified in Multiple Myeloma Using Pcr With Patient-Specific Immunoglobulin Gene Primers

Multiple Myeloma and Chronic Lymphocytic Leukemia

Multiple Myeloma: The Cells of Origin–A Two-Way Street

Methylation of the P16ink4a Gene in Multiple Myeloma